The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EORTC QLQ-C30 (QLQ-C30) symptoms in patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib vs chemotherapy treatment of physician’s choice (TPC) in OlympiAD.
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Kathryn Jean Ruddy
Stock and Other Ownership Interests - Merck; Pfizer
Patents, Royalties, Other Intellectual Property - My husband is a co-inventor of technology licensed by Mayo Clinic to AliveCor (MountainView, CA), which makes a smartphone-enabled remote ECG monitoring system. (I)
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Hanmi; Novartis; Pfizer; Roche
Research Funding - AstraZeneca
 
Elzbieta Senkus-Konefka
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clinigen Group; Egis Pharmaceuticals; Janssen; Novartis; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Egis Pharmaceuticals; Janssen; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche
 
Binghe Xu
No Relationships to Disclose
 
Susan M. Domchek
Honoraria - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Pharmamar (Inst)
 
Norikazu Masuda
Honoraria - AstraZeneca; Chugai Pharma; Pfizer; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
 
Wei Li
No Relationships to Disclose
 
Nadine M. Tung
Honoraria - AstraZeneca
Research Funding - AstraZeneca
 
Anne Caroline Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
 
Wendy Bannister
Employment - AstraZeneca
 
Carsten Dietrich Goessl
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Arnold Degboe
Employment - AstraZeneca
 
Robert Hettle
Employment - AstraZeneca
 
Pier Franco Conte
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Novartis; Roche
Research Funding - Merck Serono; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; GlaxoSmithKline; Novartis